US corporate tax reform is arguably the single policy change pharmaceutical manufacturers most want President Trump and the Republican-led Congress to get done, but now it appears a tax overhaul will be delayed until after Congress takes another swing at health care reform.
"We're going to have a phenomenal tax reform, but I have to do health care first," Trump said in an...